These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9474454

  • 1. Twice-a-day versus four-times-a-day ofloxacin treatment of external ocular infection.
    Friedlaender MH.
    CLAO J; 1998 Jan; 24(1):48-51. PubMed ID: 9474454
    [Abstract] [Full Text] [Related]

  • 2. Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II.
    Gwon A.
    Arch Ophthalmol; 1992 Sep; 110(9):1234-7. PubMed ID: 1520109
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
    Torkildsen GL, Cockrum P, Meier E, Hammonds WM, Silverstein B, Silverstein S.
    Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
    [Abstract] [Full Text] [Related]

  • 8. Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis.
    Shulman DG, Sargent JB, Stewart RH, Mester U.
    Eur J Ophthalmol; 1996 Jan; 6(4):361-7. PubMed ID: 8997575
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
    Gallenga PE, Lobefalo L, Colangelo L, Della Loggia G, Orzalesi N, Velati P, Bujtar E, Ponte F, Damiani S, Bucci MG, Bonini S, Curatola MR, Palma LA, Bonomi L, Tomazzoli Gerosa L, Pagliarusco A, Milan E, Jauch A.
    Ophthalmologica; 1999 Jan; 213(4):250-7. PubMed ID: 10420109
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis.
    Bloom PA, Leeming JP, Power W, Laidlaw DA, Collum LM, Easty DL.
    Eur J Ophthalmol; 1994 Jan; 4(1):6-12. PubMed ID: 8019124
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of efficacy and safety of ciprofloxacin and norfloxacin ophthalmic solutions.
    Adenis JP, Brasseur G, Demailly P, Malet F, Verin P, Saint-Blancat P, Retout A, Ollé P, Colin J.
    Eur J Ophthalmol; 1996 Jan; 6(3):287-92. PubMed ID: 8908436
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitis.
    Yee RW, Tepedino M, Bernstein P, Jensen H, Schiffman R, Whitcup SM, Gatifloxacin BID/QID Study Group.
    Curr Med Res Opin; 2005 Mar; 21(3):425-31. PubMed ID: 15811211
    [Abstract] [Full Text] [Related]

  • 18. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics.
    Everett SL, Kowalski RP, Karenchak LM, Landsittel D, Day R, Gordon YJ.
    Cornea; 1995 Jul; 14(4):382-7. PubMed ID: 7671609
    [Abstract] [Full Text] [Related]

  • 19. A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis.
    Yactayo-Miranda Y, Ta CN, He L, Kreutzer TC, Nentwich MM, Kampik A, Mino de Kaspar H.
    Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):993-8. PubMed ID: 19205719
    [Abstract] [Full Text] [Related]

  • 20. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
    Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.